Exscientia Dirección
Dirección controles de criterios 1/4
Exscientia's El consejero delegado es Dave Hallett , nombrado en Feb 2023, tiene un mandato de 1.08 años. posee directamente 0.001% de las acciones de la empresa, con un valor de $9.17K . La antigüedad media del equipo directivo y del consejo de administración es de 1.2 años y 3.2 años, respectivamente.
Información clave
Dave Hallett
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | 1.2yrs |
Participación del CEO | 0.001% |
Permanencia media de la dirección | 1.3yrs |
Promedio de permanencia en la Junta Directiva | 3.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade)
Feb 26Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Jan 11Earnings Update: Exscientia plc (NASDAQ:EXAI) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 12New Forecasts: Here's What Analysts Think The Future Holds For Exscientia plc (NASDAQ:EXAI)
Aug 31We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Aug 25Broker Revenue Forecasts For Exscientia plc (NASDAQ:EXAI) Are Surging Higher
Jul 21Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans
Apr 22We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Dec 30The Exscientia plc (NASDAQ:EXAI) Analysts Have Been Trimming Their Sales Forecasts
Aug 31Exscientia: Using AI To Power Drug Development
Aug 15Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth
May 29Exscientia: Drug Discovery Using AI For Sanofi And Self-Owned Pipeline
Apr 12Bullish: Analysts Just Made A Sizeable Upgrade To Their Exscientia plc (NASDAQ:EXAI) Forecasts
Jan 09CEO
Dave Hallett (54 yo)
1.2yrs
Permanencia
Dr. David Hallett, also known as Dave, Ph.D. is the Chief Operations Officer of Exscientia Limited since January 2020. He served as Chief Operating Officer at Exscientia plc since June 2022 until 2022 and...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Chief Scientific Officer | 1.2yrs | sin datos | 0.0012% £ 7.1k | |
CFO, Chief Strategy Officer & Executive Director | 3.4yrs | UK£1.92m | 0.039% £ 233.0k | |
Chief Medical Officer | 2yrs | sin datos | 0.028% £ 166.7k | |
Chief Information Officer | 1.8yrs | sin datos | sin datos | |
Vice President of Investor Relations | no data | sin datos | sin datos | |
Vice President of Legal & Company Secretary | 1.3yrs | sin datos | sin datos | |
Executive Vice President of Corporate Development | less than a year | sin datos | sin datos | |
Chief People Officer | 1.6yrs | sin datos | sin datos | |
Chief Business Officer | no data | sin datos | sin datos | |
Chief Data Officer | less than a year | sin datos | sin datos | |
Executive Vice President of Precision Medicine | 1.3yrs | sin datos | sin datos |
1.3yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: EXAIEl equipo directivo de la empresa no se considera experimentado ( 1.4 años de permanencia media), lo que sugiere un nuevo equipo.
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Chief Scientific Officer | less than a year | sin datos | 0.0012% £ 7.1k | |
CFO, Chief Strategy Officer & Executive Director | 3.4yrs | UK£1.92m | 0.039% £ 233.0k | |
Interim Independent Non-Executive Chairman | 3.2yrs | UK£282.03k | 0.056% £ 335.2k | |
Independent Non-Executive Director | 6.6yrs | UK£201.69k | 0.046% £ 274.7k | |
Independent Non-Executive Director | 3.9yrs | sin datos | sin datos | |
Independent Director | less than a year | UK£178.86k | 0.0052% £ 31.4k |
3.3yrs
Permanencia media
50yo
Promedio de edad
Junta con experiencia: La junta directiva de EXAI se considera experimentada (3.2 años de antigüedad promedio).